What would healthcare look like if GPs had the time, tools, and data to treat every patient like an elite athlete?

What would healthcare look like if GPs had the time, tools, and data to treat every patient like an elite athlete?

In this episode of Beyond Longevity, I am joined by Dr Angus Perry, a practising GP, clinical AI builder, and performance-medicine enthusiast with experience supporting Formula One teams and elite athletes. Dr Angus is focused on closing the gap between what preventive medicine can achieve and what is realistic inside a ten-minute GP appointment.

He shares the path that led him here: a childhood ambition to become a GP, an early pull toward technology, and a personal family experience with chronic disease that clarified why the current model is failing both clinicians and patients. We talk candidly about GP burnout, time pressure, and why meaningful lifestyle support is so hard to deliver at scale.

Two data points frame his urgency:

-The Lancet Standing Commission’s 2024 report estimates that around 45% of dementia cases are potentially preventable by addressing 14 modifiable risk factors across the life course.

-A 2018 JAMA Network Open cohort study of 122,007 adults undergoing treadmill testing found cardiorespiratory fitness was inversely associated with long-term all-cause mortality, with a median follow-up of 8.4 years and no observed “upper limit” of benefit.

Dr Angus then walks through the two-part platform he is building:

  1. A clinician-facing tool that helps generate chronic disease and preventive-care plans (including areas such as diabetes, hypertension, and dementia prevention).

-A patient-facing app designed around daily check-ins, habit tracking, nudges, milestones, and adherence dashboards — aiming to “close the accountability loop” between appointments giving clinicians the data they need and whilst keeping patients genuinely engaged with their own health in-between appointments

We also dig into what responsible clinical AI looks like in practice: hallucination risk, governance, compliance, and the line between augmentation and undermining the clinician–patient relationship. And we explore whether tools used in elite sport (including dynamometry for strength and fatigability) could become more relevant in ageing and sarcopenia care — including for patients using GLP-1 medications.

Dr Angus is clear about where things stand today: the app has had a very promising soft launch, clinician feedback driving iteration, early NHS pilot conversations, and outcomes data still being gathered. The episode closes with a sober assessment of where healthcare may be heading without greater patient empowerment — and a reminder that many of the biggest longevity gains are still driven by environment and lifestyle, not expensive interventions.

Rapid-fire highlights: why passion beats rigid planning, the single habit he prioritises most (sleep), what he would have done if medicine had not worked out, and why a simple daily gratitude practice can have outsized downstream effects.

Links:

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

Association of Cardiorespiratory Fitness and Mortality Among Adults Undergoing Exercise Treadmill Testing

GeneralPractice.AI | Healthcare

Dr. Angus Perry - PAP - Pioneered Athlete Performance

https://uk.linkedin.com/in/dr-angus-perry-b49918128

In this episode:

00:00 — Welcome + introducing Dr Angus Perry, GP and clinical AI builder

01:39 — Origin story: why general practice, early tech roots, and high-performance medicine

03:26 — Why standard GP wasn't enough: chronic disease, system limits, and burnout

05:12 — The personal wake-up call: family experience and lifestyle-driven disease

08:55 — From experiments to product: early LLM tools and the lifestyle research that changed everything

10:52 — The evidence for prevention: dementia risk, fitness and mortality

13:12 — Introducing the platform: clinician tool and patient app for behaviour change

14:07 — Patient activation and empowerment: making people the CEO of their own health

15:57 — How the app works: risk factors, activation scoring, check-ins, and accountability loops 19:26 — Early launch feedback, adoption questions, and the road to NHS pilots

21:05 — What's next: AI agents, EHR integration, and removing workflow friction

22:56 — Clinician concerns about AI: augmentation vs replacement, and can AI extend healthspan? 25:08 — ChatGPT for health: useful, but the doctor–patient bond still matters

26:03 — What responsible AI means in healthcare: governance, risk, and regulation

27:38 — Does technology change how he practises as a GP?

28:20 — From Formula One to primary care: treating patients like elite athletes

31:40 — Performance technology that could reach clinics: muscle testing and the realities of G-force data

33:25 — Dynamometry explained: measuring strength, imbalances, and fatigability

35:41 — Why muscle mass is a longevity cornerstone — and how it declines

38:01 — Where GP and preventive medicine are headed in five years

40:08 — Is longevity medicine only for the wealthy? The 70/15/5 reality

43:28 — Rapid-fire advice and final takeaways on making innovation practical

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(32)

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Aug 1h 6min

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Aug 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Aug 48min

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving fr...

26 Jul 1h 2min

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topic...

19 Jul 52min

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

On Beyond Longevity, host Daphna speaks with Dr Sundeep Dugar, PhD, co-founder of BlueOakNx and the scientists behind the blockbuster cholesterol medicines Zetia (ezetimibe) and Vytorin. He explains h...

12 Jul 59min

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switz...

5 Jul 1h

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientif...

28 Jun 57min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
liberal-halvtime
rekommandert
jss
villmarksliv
dekodet-2
abels-tarn
sinnsyn
vett-og-vitenskap-med-gaute-einevoll
fjellsportpodden
rss-overskuddsliv
rss-rekommandert
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
diagnose
rss-inn-til-kjernen-med-sunniva-rose
nordnorsk-historie